Oral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)

Diabetes mellitus, type 2, is a chronic disease which can be linked with many complications in connexion with impaired blood glucose balance.

It diagnosis in risky subjects such as in patients with medical history of gestational diabetes is therefore imperative to prevent its complications.

Actual guidelines recommend an oral tolerance glucose test, measuring glucose levels after oral glucose intake (75g), between 6 an 12 weeks after childbirth. But studies reveal a low diagnosis rate.

The study of the current practices of diagnosis methods seem to be essential in order to improve this diagnosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gestational Diabetes Diabetes Mellitus Diabetes, Gestational Endocrine System Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pregnancy Complications Urogenital Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Centre hospitalier Lucien Hussel

Vienne, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients followed in endocrinology at the hospital of Vienne for gestational diabetes, whom benefited an educational therapy session between the 01/01/2016 and the 31/12/2016 inclusive.

Exclusion criteria

Minor patients or under legal protection (guardianship)
Patients who not speak french
Patients who did not declared an attending physician
Refusal to take part in the survey
Patients lost to follow-up before childbirth
Patients whose pregnancy ended by foetal death.
Pre-existing diabet before pregnancy

Treatment and study plan

frequency of diabetes mellitus, type 2, diagnosis in patients with medical history of gestational diabetes.

Other

Patients will be contacted by mail with sending of the information notice to ask them to participate in the study.

If they don't reply, the subjects will be called by phone by the investigator to collect their non opposition of participation at the study.

During this call, the investigator will be able to answer all the questions about the study.

The report of this telephone conversation will be register in the medical file of the patient.

Then, we will collect informatic data from the hospital concerning the patients.

After that they will be contacted by phone to answer a survey. Beside, another secure survey will be send by email to each patient's family doctor.

To finish, crossing data between those of the patients and the family doctor and anonymisation of the data.

Other names: Evaluate the frequency of diabetes mellitus, type 2, diagnosis with an oral glucose tolerance test between 6 and 12 weeks after childbirth in patients with medical history of gestational diabetes.

Primary outcomes

Performing oral glucose tolerance test in order to detect type 2 diabetes

Time frame: Month 6

Performing oral glucose tolerance test between 6 and 12 weeks after childbirth. As recommended by actual World Health Organisation (WHO) guidelines

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Descriptive Study of the Diabetes Mellitus, Type 2 Diagnosis Methods During Postpartum Period in Patients With Medical History of Gestational Diabetes Whom Benefited an Educational Therapy Session.

Important dates

Study start: 2018
Primary completion: 2019
Study completion: 2019
First posted: Aug 23, 2018
Registry last updated: Aug 21, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed